Please find enclosed Press Release on Sameer Hiremath''s appointment as Chairman and Managing Director.

September 23, 2026 BSE Limited, National Stock Exchange of India Limited, P J Towers, Exchange Plaza, Dalal Street, Bandra-Kurla Complex, Bandra, Mumbai - 400 001. Mumbai - 400 051. Scrip Code: 524735 Symbol: HIKAL Dear Sir/Madam, Subject: Press Release- Hikal Shareholders approve Sameer Hiremath’s appointment as Chairman and Managing Director at 38th AGM. Please find enclosed herewith, a copy of the press release titled “Hikal Shareholders approve Sameer Hiremath’s appointment as Chairman and Managing Director at 38th AGM”. This is for your information and records. Thank you, Yours Sincerely, For Hikal Limited, Rajasekhar Reddy Company Secretary & Compliance Officer Encl: As above Hikal Ltd. Admin. Office: Great Eastern Chambers, 6th Floor, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India. Tel. + 91–22–6277 0299, + 91–22–6866 0300 Regd. Office: 717/718, Maker Chambers - 5, Nariman Point, Mumbai - 400 021, India. Tel. +91-22 6277 0477. Fax: + 91-22 6277 0500 www.hikal.com info@hikal.com CIN: L24200MH1988PTC048028 Hikal Shareholders Approve Sameer Hiremath’s Appointment as Chairman & Managing Director at 38th  Majority of shareholders support appointment of Sameer Hiremath  Commenced commercial production of Personal Care products at the new cGMP-compliant multipurpose facility in Gujarat Mumbai, September 23, 2026: Hikal Limited, a trusted life sciences partner to global pharmaceutical, crop protection, animal health and specialty chemical companies, today announced that its shareholders have approved the appointment of Mr. Sameer Hiremath as Chairman & Managing Director of the Company for a five-year term, effective October 1, 2026 to September 30, 2031. The appointment was approved at Hikal’s 38th Annual General Meeting. Shareholders also approved the audited financial statements for FY2025-26, the final dividend of Rs. 0.40 (Forty Paise) and the re- appointment of Mr. Sarangan Suresh as Executive Director. Mr. Sameer Hiremath has been associated with Hikal’s Board since May 1999 and was last reappointed as Managing Director at the Company’s 2021 Annual General Meeting. His continued association with the Company spans almost three decades, during which Hikal has expanded its capabilities across pharmaceuticals, crop protection and emerging life-sciences businesses. Commenting on the occasion, Mr. Sameer Hiremath, Chairman & Managing Director, Hikal Limited, said: “FY2025-26 was a year of resilience, disciplined execution and capability building for Hikal. We strengthened our core businesses while making focused investments in high-value capabilities, including complex chemistries, HPAPI, CDMO and advanced R&D infrastructure. As we move forward, our focus will remain on strengthening our core businesses, accelerating our diversification into new geographies and growing our emerging business verticals like Animal Health and Specialty Chemicals which include Personal Care. Under the current plan, we have healthy cash flows and strong financials allowing us to focus on deepening customer partnerships and continuing to invest in technology, quality and manufacturing excellence” The Company recently announced the commencement of commercial production of Personal Care products at its new cGMP-compliant multipurpose facility at Panoli, Gujarat. The facility marks Hikal’s entry into commercial-scale manufacturing for the global beauty and personal care industry. Hikal has also been awarded the EcoVadis Gold Medal rating, placing it among the top 5% of companies assessed globally for sustainability performance. About Hikal Limited Established in 1988, Hikal is a reliable partner to companies in the Pharmaceutical, Animal Health, Biotech, Personal Care and Specialty Chemical industries. We manufacture and supply quality Active Ingredients, Intermediates, Biocides to the global life sciences industry. Hikal has five manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bengaluru (Jigani) and a world-class Research & Technology centre at Pune. Our facilities have been inspected and certified by the Global Regulatory Authorities. We create and deliver sustainable solutions for our partners and customers across the life-sciences value chain. Hikal believes in inclusive growth that embraces all constituents. Hikal is one of the first Indian life-sciences companies to receive the Responsible Care® certification and has also been awarded the EcoVadis Gold Medal rating, placing it among the top 5% of companies assessed globally for sustainability performance. We accord top priority to the health and safety of our employees by adopting best practices in manufacturing.